News
Disease model on a chip: researchers develop Barret's esophageal reflux disease
Thursday, 06 July 2023 09:10Scientists at the Wyss Institute at Harvard University in Boston have recreated a model of reflux disease (barrett's disease) in vitro. The goal is to gain a better understanding of the cellular and molecular triggers of this disease and to develop appropriate drug therapies.
Berlin: International Congress on Multiorgan-on-a-Chip with overwhelming contributions
Saturday, 01 July 2023 09:32This year's World Summit on Microphysiological Systems was held in Berlin from June 26 to 30. 1,297 participants from numerous countries had registered. It was impressive to see how many young scientists dedicated themselves to the development of animal-free methods with the ultimate goal of finding better treatments through human-specific research, reducing the financial burden and time required to do so, and replacing animal experimentation.
Bayer manager outlines steps to phase out animal testing
Friday, 23 June 2023 12:31Dr. Eckhard von Kreutz, former senior vice president and head of translational sciences at Bayer Pharmaceuticals, recently described on the LinkedIN platform eight steps necessary to completely replace animal testing.
Dynamic42: Growth financing in the mid-seven-digit range
Tuesday, 20 June 2023 13:44The Jena-based biotechnology company Dynamic42, a spin-off from the Center for Sepsis Control and Care (CSCC) at Jena University Hospital, has reached a milestone. It has secured growth financing from bm-t Beteiligungsmanagement Thüringen GmbH (bm-t) and another financier.
Düsseldorf-based start-up DNTOX receives €1.4 million in investment funding
Monday, 19 June 2023 11:59DNTOX GmbH, based in Düsseldorf, Germany, is a bio-analytical testing laboratory that screens chemicals for its potential to disrupt human brain development and cause developmental neurotoxicity (DNT) without using animals. With its service, the research team has convinced investors and can now dispose of 1.4 million euros in start-up funding.
Animal-free drug development in the U.S.: Addressing NAMs builds confidence
Monday, 19 June 2023 11:47An article from Nature Medicine provides a good insight into the current debate about the recognition of results from animal-free methods in drug development.
New Environmental Protection Act in Canada: "Leap into a new era of research and innovation"
Friday, 16 June 2023 13:37A few days ago, the Environmental Protection Act, Bill S-5, was revised in Canada. It includes amendments that require the Canadian government to replace or reduce animal testing for toxicity testing of chemicals where possible and to publish a plan within the next two years to encourage the development and timely incorporation of alternative strategies for toxicity testing.
Research award for rare diseases announced
Friday, 16 June 2023 09:56The Eva Luise and Horst Köhler Foundation, in cooperation with the association ACHSE e. V., has offered a research prize for rare diseases since 2008.
Saarland: Innovative lung infection model with biofilm
Thursday, 15 June 2023 09:54Researchers at the Helmholtz Institute for Pharmaceutical Research Saarland (HIPS), headed by Prof. Dr. Claus-Michael Lehr, have developed a novel method to specifically place biofilms on lung cells in the laboratory. The model system produced by means of "bioprinting" should help to better understand infection processes and assist in the research of new active substances.
Call for Entries: International Eppendorf & Science Prize 2023
Monday, 12 June 2023 13:50The annual Eppendorf & Science Prize for Neurobiology is an international award which honors early-career scientists for their outstanding contributions to neurobiological research based on methods of molecular and cell biology.
Dr. rer. nat.
Menschen für Tierrechte - Tierversuchsgegner Rheinland-Pfalz e.V.